Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Role of Endoscopy in the Management of Malignant Hilar Obstruction

Publication Date: May 20, 2021

Last Updated: March 14, 2022

Recommendations

In patients with unresectable MHO undergoing endoscopic palliative endoscopic stent placement, the panel suggests the following:

SEMSs compared with PSs in patients with a short life expectancy (<3 months) or those who place high value on avoiding repeated interventions.
PSs compared with SEMSs if an optimal drainage strategy has not been established.
Otherwise, either stent type may be used based on local expertise and physician preference.

( Low , Conditional (weak) )

612

Overview

Title

Role of Endoscopy in the Management of Malignant Hilar Obstruction

Authoring Organization